Global Clinical Trial Supply and Logistic for Pharmaceutical Market Growth (Status and Outlook) 2025-2031

Global Clinical Trial Supply and Logistic for Pharmaceutical Market Growth (Status and Outlook) 2025-2031

The global Clinical Trial Supply and Logistic for Pharmaceutical market size is predicted to grow from US$ 2308 million in 2025 to US$ 3767 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.

A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures. Clinical Trial Supply and Logistic for Pharmaceutical management is imperative for avoiding overproduction, inventory expiration, and oversupply. With the escalating costs of drug discovery, Clinical Trial Supply and Logistic for Pharmaceutical is gaining more significance. In addition, the implementation of stricter handling requirements for a variety of biopharmaceutical products entering clinical trials, Clinical Trial Supply and Logistic for Pharmaceutical strategy needs to be constantly overhauled. This also calls for integrating several third-party vendors across all stages of clinical development.

Global clinical trial supply and logistic for pharmaceutical market key players include Thermo Fisher Scientific, Catalent Pharma Solutions, Almac Group, Parexel International, etc., they hold a share about 70% altogether. Americas is the biggest market, which has about 60% shares of the global market. Two key types are Logistics & Distribution, Supply Chain Management, which hold a share over 60%. Phase III is the main application with a share over 50%.

LPI (LP Information)' newest research report, the “Clinical Trial Supply and Logistic for Pharmaceutical Industry Forecast” looks at past sales and reviews total world Clinical Trial Supply and Logistic for Pharmaceutical sales in 2024, providing a comprehensive analysis by region and market sector of projected Clinical Trial Supply and Logistic for Pharmaceutical sales for 2025 through 2031. With Clinical Trial Supply and Logistic for Pharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial Supply and Logistic for Pharmaceutical industry.

This Insight Report provides a comprehensive analysis of the global Clinical Trial Supply and Logistic for Pharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Trial Supply and Logistic for Pharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Trial Supply and Logistic for Pharmaceutical market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial Supply and Logistic for Pharmaceutical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial Supply and Logistic for Pharmaceutical.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Supply and Logistic for Pharmaceutical market by product type, application, key players and key regions and countries.

Segmentation by Type:
Logistics & Distribution
Manufacturing and Packaging
Supply Chain Management
Other

Segmentation by Application:
Phase I
Phase II
Phase III

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Catalent Pharma Solutions
Almac Group
Parexel International
UDG Healthcare
PCI Services
Marken
Klifo A/S.
Walden Group
Bilcare Limited
Biocair

Please note: The report will take approximately 2 business days to prepare and deliver.